Free tool
FAERS Monitor: Zyloprim
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 016084 or its brand name (Zyloprim, Allopurinol). Reports on generic versions are filed under their own applications.
Reports
157,733
Serious
129,250
82% of reports
Hospitalization
77,037
Death reported
22,110
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- diarrhoea8,831
- fatigue8,385
- dyspnoea8,016
- nausea7,396
- death6,985
- acute kidney injury6,871
- off label use6,805
- pyrexia6,125
- pneumonia5,754
- asthenia5,712
- anaemia5,511
- drug ineffective5,239
- dizziness5,175
- renal failure4,779
- fall4,725
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,482 |
| 2005 | 2,097 |
| 2006 | 2,078 |
| 2007 | 1,811 |
| 2008 | 2,226 |
| 2009 | 2,744 |
| 2010 | 3,358 |
| 2011 | 4,397 |
| 2012 | 5,349 |
| 2013 | 5,158 |
| 2014 | 5,525 |
| 2015 | 8,242 |
| 2016 | 9,189 |
| 2017 | 9,475 |
| 2018 | 12,939 |
| 2019 | 13,166 |
| 2020 | 12,834 |
| 2021 | 11,186 |
| 2022 | 10,728 |
| 2023 | 9,249 |
| 2024 | 8,953 |
| 2025 | 9,066 |
| 2026 | 6,469 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,896,426 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| acute kidney injurySignal | 6,871 | 6.2 | 6.1 | 28,964 |
| renal failureSignal | 4,779 | 4.9 | 4.8 | 14,568 |
| anaemiaSignal | 5,511 | 3.9 | 3.8 | 11,835 |
| pneumoniaSignal | 5,754 | 2.4 | 2.3 | 4,661 |
| pyrexiaSignal | 6,125 | 2.4 | 2.3 | 4,918 |
| astheniaSignal | 5,712 | 2.0 | 2.0 | 3,042 |
| fall | 4,725 | 1.9 | 1.9 | 2,037 |
| dyspnoea | 8,016 | 1.9 | 1.9 | 3,467 |
| diarrhoea | 8,831 | 1.8 | 1.8 | 3,418 |
| fatigue | 8,385 | 1.4 | 1.4 | 1,161 |
| dizziness | 5,175 | 1.4 | 1.4 | 567 |
| nausea | 7,396 | 1.2 | 1.2 | 376 |
| death | 6,985 | 1.1 | 1.1 | 45 |
| off label use | 6,805 | 1.0 | 1.0 | 9 |
| drug ineffective | 5,239 | 0.5 | 0.5 | 2,346 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.